Active immunization with Brucella abortus S19 phage lysate elicits serum IgG that protects guinea pigs against virulent B. abortus and protects mice by passive immunization

Biologicals

Volumn 45, Issue , 2017, Pages 27-32

  Jain, Lata ^a   Rawat, Mayank ^a   Ramakrishnan, Saravanan ^a   Kumar, Bablu ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Brucellosis; Cell mediate immune response; Humoral response; Passive mouse protection assay; Phage lysate; Protective efficacy

Indexed keywords

BRUCELLA VACCINE; CARBOHYDRATE; IMMUNOGLOBULIN G; PROTEIN; BACTERIUM ANTIBODY;

ACTIVE IMMUNIZATION; ADULT; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOPHAGE; BRUCELLA ABORTUS; BRUCELLOSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PASSIVE MOUSE PROTECTION TEST; PATHOGENESIS; ANIMAL; BOVINE; CHEMISTRY; GUINEA PIG; IMMUNOLOGY; VIROLOGY;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIOPHAGES; BRUCELLA ABORTUS; BRUCELLOSIS; CATTLE; GUINEA PIGS; IMMUNIZATION, PASSIVE; MICE;

EID: 85007336120     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2016.10.006     Document Type: Article

References (46)

1. [1] Mantur, B.G., Amarnath, S.K., Brucellosis in India- a review. J Biosci 33 (2008), 539–547.
2. [2] Manish, K.P., Rajesh, C., Teena, R., Sunil, K., Brucellosis-an updated review of the disease. Indian J Anim Sci 83 (2013), 3–16.
3. [3] Cutler, S.J., Whatmore, A.M., Commander, M.J., A review on Brucellosis-new aspects of an old disease. J Appl Microbiol 98 (2005), 1270–1281.
4. [4] Stevens, M.G., Olsen, S.C., Cheville, N.F., Comparative analysis of immune responses in cattle vaccinated with Brucella abortus 19 or RB51. Vet Immunol Immunopathol 44 (1995), 223–235.
5. [5] Schurig, G.G., Sriranganathan, N., Corbel, M., Brucellosis vaccines: past, present and future. Vet Microbiol 90 (2002), 479–496.
6. [6] Oliveira, S.C., Harms, J.S., Banai, M., Splitter, G.A., Recombinant Brucella abortus proteins that induce proliferation of gamma interferon secretion by CD4+ T cells from brucella vaccinated mice and delayed-type hypersensitivity in sensitized Guinea pigs. Cell Immunol 172 (1996), 262–268.
7. [7] Vemulapalli, R., Cravero, S., Clavert, C.L., Toth, T.E., Sriranganathan, N., Boyle, S.M., et al. Characterization of specific immune response of mice inoculated with recombinant vaccine virus expressing an 18 kilodalton outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol 7 (2000), 114–118.
8. [8] Al-Mariri, A., Tibor, A., Mertens, P., Bolle, X., Michel, P., Godfroid, J., et al. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun 69 (2001), 4816–4822.
9. [9] Pontes, D.S., Dorella, F.A., Ribeiro, L.A., Miyoshi, A., Le Loir, Y., Gruss, A., et al. Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen. J Drug Target 11 (2003), 489–493.
10. [10] Mallick, A.I., Singha, H., Chaudhuri, P., Nadeem, A., Khan, S.A., Dar, K.A., et al. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection. Vaccine 25 (2007), 3692–3704.
11. [11] Crawford, R.M., Verg, L., Yaun, L., Hadfield, T.L., Warren, R.L., Drazek, E.S., et al. Deletion of purE attenuate Brucella melitensis infection in mice. Infect Immun 64 (1996), 2188–2192.
12. [12] Leclerq, S., Harms, J.S., Roshina, G.M., Azeveda, V., Olivereira, S.C., Induction of a Th1 type immune response but not protective immunity by intramuscular DNA immunization with Brucella abortus GroEL heat shock gene. J Med Microbiol 51 (2002), 20–26.
13. [13] Velikovsky, C.A., Cassataro, J., Giambartolomei, G.H., Goldbaum, F.A., Estein, S., Bowden, R.A., et al. A DNA vaccine encoding luminase synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 46 (2002), 182–187.
14. [14] Munoz, C., Andrews, E., Rivers, R., Gonzalez, A., Moraga, G., Fotlch, H., et al. Intra spleen delivery of a DNA vaccine encoding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells. Infect Immun 72 (2004), 2081–2087.
15. [15] Onate, A.A., Cespedes, S., Cabrera, A., Rivers, R., Gonzalez, A., Munoz, C., et al. A DNA vaccine encoding Cu-Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 67 (2005), 986–988.
16. [16] Sulakvelidze A, Pasterneck R, Brown T. Method for vaccination of poultry by using Bacteriophage lysate bacterin. US 2009/0297561 A1.
17. [17] Renukaradhya, G.J., Isloor, S., Rajasekhar, M., Epidemiology, zoonotic aspects, vaccination and control/eradication of brucellosis in India. Vet Microbiol 90 (2002), 183–195.
18. [18] Singh, B.B., Dhand, N.K., Gill, J.P.S., Economic losses occurring due to brucellosis in Indian livestock populations. Prev Vet Med 119 (2015), 211–215.
19. [19] Jain, L., Rawat, M., Prajapati, A., Tiwari, A.K., Kumar, B., Chaturvedi, V.K., et al. Protective immune response of aluminium hydroxide gel adjuvanted phage lysate of Brucella abortus S19 in mice against direct virulent challenge with B. abortus 544. Biologicals 43 (2015), 369–376.
20. [20] Chachra, D., Kaur, H., Chandra, M., Saxena, H.M., Isolation electron microscopy and physico-chemical characterization of a brucellaphage against Brucella abortus vaccine strain 19. Internet J Microbiol, 10(2), 2012.
21. [21] Pandey, S., Chachra, D., Chandra, M., Saxena, H.M., Protein profiling and physico-chemical characterization of an isolated phage against Brucella abortus Strain 19. Afr J Microbiol Res 7 (2013), 1233–1238.
22. [22] Jain, L., Rawat, M., Kumar, V., Kerketta, P., Chachra, D., Ramane, S., et al. Morphological and molecular characterization of indian isolate of brucellaphage. J Pure Appl Microbiol 8 (2014), 4087–4097.
23. [23] Jain, L., Rawat, M., Kumar, V., Chachra, D., Characterization of Brucellaphage using RAPD and microsatellite repeat marker. J Pure Appl Microbiol 9 (2015), 686–690.
24. [24] Sambrook, J., Russell, D.W., Molecular cloning: a laboratory manual. third ed., 2001, Cold Spring Harbor.
25. [25] Indian Pharmacopoeia vol. III: section 2.2.11, 2014, Government of India, Ministry of Health and Family Welfare. Indian Pharmacopoeia Commission, Ghaziabad.
26. [26] Briggs, D.J., Skeeles, J.K., An enzyme linked immunosorbent assay for detecting antibodies to Pasteurella multocida in chickens. Avian Dis 28 (1984), 208–215.
27. [27] Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Method 65 (1983), 55–63.
28. [28] Haddad, E.E., Mashly, M.M., Chicken growth hormone, tri-iodo-thyronine and thyrotropin releasing hormone modulation of levels of chicken natural cell mediated toxicity. Dev Comp Immunol 15 (1991), 65–71.
29. [29] OIE, Bovine brucellosis., sixth ed. OIE manual of diagnostic tests and vaccines for terrestrial animals, vol. 2, 2008, World Organization for Animal Health, Paris, France, 1–35.
30. [30] Salmakov, K.M., Fomin, A.M., Plotnikova, E.M., Safina, G.M., Galimova, G.M., Salmakova, A.V., et al. Comparative study of the immunobiological properties of live brucellosis vaccines. Vaccine 28 (2010), F35–F40.
31. [31] Araya, L.N., Elzer, P.H., Rowe, G.E., Enright, F.M., Winter, A.J., Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J Immunol 143 (1989), 3330–3337.
32. [32] Montaraz, J.A., Winter, A.J., Comparison of living and nonliving Vaccines for Brucella abortus in BALB/c Mice. Infect Immun 53 (1986), 245–251.
33. [33] Winter, A.J., Duncan, J.R., Santisteban, C.G., Douglas, J.T., Adams, L.G., Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice. Infect Immun 57 (1989), 3438–3444.
34. [34] Montaraz, J.A., Winter, A.J., Hunter, D.M., Sowa, B.A., Wu, A.M., Adams, L.G., Protection against Brucella abortus in mice with O- polysaccharide-specific monoclonal antibodies. Infect Immun 51 (1986), 961–963.
35. [35] Phillips, M., Deyoe, B.L., Canning, P.C., Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen. Am J Vet Res 50 (1989), 2158–2161.
36. [36] Elzer, P.H., Jacobson, R.H., Nielsen, K.H., Douglas, J.T., Winter, A.J., BALB/c mice infected with Brucella abortus express protracted polyclonal responses of both IgG2a and IgG3 isotypes. Immunol Lett 42 (1994), 145–150.
37. [37] Canning, P.C., Deyoe, B.L., Roth, J.A., Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus. Am J Vet Res, 49, 1988, 160.
38. [38] Winter, A.J., Duncan, J.R., Santisteban, C.G., Douglas, J.T., Adams, L.G., Capacity of passively administered antibody to prevent the establishment of Brucella abortus infection in mice. Infect Immun 57 (1989), 3438–3444.
39. [39] Hoffmann, E.M., Houle, J.J., Contradictory roles for antibody and complement in the interaction of Brucella abortus with its host. Crit Rev Microbiol 21 (1995), 153–163.
40. [40] Ko, J., Splitter, G.A., Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 16 (2003), 65–78.
41. [41] Perkins, S.D., Smither, S.J., Atkins, H.S., Towards a Brucella vaccine for humans. FEMS Microbiol Rev 34 (2010), 379–394.
42. [42] Titball, R.W., Vaccines against intracellular bacterial pathogens. Drug Discov Today 13 (2008), 596–600.
43. [43] Sulitzeanu, D., Mechanism of immunity against Brucella. Nature 205 (1965), 1086–1088.
44. [44] Pardon, P., Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum. Ann Immunol 128 (1977), 1025–1037.
45. [45] Bascoul, S., Cannat, A., Huguet, M., Serre, A., Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum. Immunol 35 (1978), 213–221.
46. [46] Plommet, M., Plommet, A., Immune serum-mediated effects on brucellosis evolution in mice. Infect Immun 41 (1983), 97–105.